Killed specific viral vaccines for therapeutic use in chronic viral infections
Barinskiĭ, I.F.; Nesterchuk, S.L.
Voprosy Virusologii 40(1): 5-8
1995
ISSN/ISBN: 0507-4088 PMID: 7740789 Document Number: 451591
Document emailed within 1 workday
Related Documents
Tremolada, F.; Fattovich, G.; Panebianco, G.; Ongaro, G.; Realdi, G. 1980: Suppressor cell activity in viral and non-viral chronic active hepatitis Clinical and Experimental Immunology 40(1): 89-95De Bree, G.J.; van Leeuwen, E.M.M.; ten Berge, R.J.M. 2007: Immunological defense to viral infections: focus on virus-specific T cells Nederlands Tijdschrift Voor Geneeskunde 151(44): 2440-2444
Chimbru, V.I.; Barinskiĭ, I.F.; Kantorovich, R.A.; Semendiaeva, M.E.; Lorie, N.I. 1975: Use of the iodine test for the purpose of detection of hypergammaglobulinemia in chronic viral hepatitis and other chronic infections Laboratornoe Delo 11: 693
Fusillo, A. 1973: Effect of small doses of emetine in the therapy of virus diseases. New specific therapeutic method in viral hepatitis Minerva Medica 64(3): 129-132
Midulla, M. 1974: Viral infections and chronic bronchopneumopathies. Isolation of cytomegalovirus in 2 cases Minerva Pediatrica 26(4): 173-187
Qian, Z.W.; Mao, S.J.; Cai, X.C.; Zhang, X.L.; Gao, F.X.; Lu, M.F.; Shao, X.S.; Li, Y.Y.; Yang, X.K.; Zhuo, Y.A. 1990: Viral etiology of chronic cervicitis and its therapeutic response to a recombinant interferon Chinese Medical Journal 103(8): 647-651
Saracco, G.; Rizzetto, M. 1999: Chronic viral hepatitis caused by B and C virus: diagnostic and therapeutic trends Recenti Progressi in Medicina 90(11): 595-600
Babinets, L.S.; Shaihen, O.R.; Homyn, H.O.; Halabitska, I.M. 2019: Specific aspects of clinical course in case of combination of chronic pancreatitis and concomitant viral hepatitis C Wiadomosci Lekarskie 72(4): 595-599
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Galkina, M.V.; Volkova, V.A. 1979: Comparative study of the therapeutic action of anti-influenza gamma-globulins obtained by donor vaccination with live and killed vaccines Voprosy Okhrany Materinstva i Detstva 24(12): 16-19
Hansen, T.W.; Gaustad, P.; Rollag, H.; Abrahamsen, T.G.; Finne, P.H. 1993: Diagnosis and treatment of infections in a neonatal unit--viral infections, spirochete infections and toxoplasma infections Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(14): 1701-1705
Grado, C.; Contreras, G.; Suárez, M. 1977: I. Viral vaccines. Vaccines of common use Revista Chilena de Pediatria 48(2): 94-98
Hottle, G. 1976: Vaccines. VI. Further advances in viral vaccines Gaceta Medica de Mexico 111(4): 279-284
Minuk, G.Y.; Uhanova, J.; Kaita, K.D. 2000: The prevalence of intrinsic host risk factors associated with progressive disease in patients with chronic hepatitis C viral infections Canadian Journal of Public Health 91(3): 171-175
Krivorutchenko, I.L. 1999: Use of muramyl peptides in viral vaccines Voprosy Virusologii 44(1): 4-8
van Gelder, P.; Makoschey, B. 2012: Production of viral vaccines for veterinary use Berliner und Munchener Tierarztliche Wochenschrift 125(3-4): 103-109
Aymard, M. 1996: Evaluation methodology of viral vaccines Therapie 51(4): 439-443
Melnick, J.L. 1989: Viral vaccines: achievements and challenges Acta Virologica 33(5): 482-493
Peetermans, J. 1996: Factors affecting the stability of viral vaccines Developments in Biological Standardization 87: 97-101
Gendon, I.Z. 2003: Mucosal viral vaccines: progress and problems Voprosy Virusologii 48(4): 4-10